Skip to main content

Avive Solutions

By Emily Olsen | 02:41 pm | March 21, 2022
The device, which is not yet cleared by the FDA, alerts bystanders to a potential cardiac event nearby and guides them to the scene.
By Dave Muoio | 03:57 pm | July 01, 2020
Also: NexHealth's $15 million Series A, Avive Solutions' $7 million raise and Cyclica's $16.9 million Series B.